Loop Medical, a start-up based from Switzerland’s École Polytechnique Fédérale de Lausanne (EPFL), has entered a collaboration agreement with French firm Cerba HealthCare for the development of a new needleless, palm-sized device to provide pain-free blood sampling.

Using the new device, Loop Medical intends to simplify the process of obtaining blood samples by facilitating at-home use and eliminating the need for professional help.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Under terms of the alliance, Loop Medical will leverage Cerba HealthCare’s technical, scientific and medical support to complete the development and finalise market-access strategy as well as commercialisation of the new device.

Loop Medical founder and CEO Arthur Queval said: “We are thrilled to announce this strategic partnership that is proof of Loop Medical’s potential to revolutionise blood sampling by finding a solution that will not only improve the patient’s experience, but the samplers’ safety and the traceability of samples.”

“It will be designed to draw an amount that will be sufficient for an expanded range of tests in approximately the same duration that is taken for a conventional blood draw.”

The device will come with a connectivity system that will enable traceability of the sample throughout the process.

It will be designed to draw an amount that will be sufficient for an expanded range of tests in approximately the same duration that is taken for a conventional blood draw.

Cerba HealthCare Innovation and Development director Jérôme Sallette said: “This partnership with Loop Medical shows we are following through with our open-innovation strategy that involves identifying early on innovative start-ups, and supporting them in their development to improve our patients’ experiences, while offering access to the most innovative tests.”